Αποτελέσματα Αναζήτησης
Pocket Guide for asthma management and prevention for adults and children older than 5 years (updated 2020). Summary for primary health care providers, to be used in conjunction with the main GINA report. Difficult-to-treat and severe asthma in adolescent and adult patients. Diagnosis and Management.
Treatment: One regimen used in two reviewed studies is budesonide inhalation suspension, 1 mg twice daily for 7 days at the first sign of respiratory tract infection-associated symptoms. Potential benefits: The main benefit during respiratory tract infections is a reduction in exacerbations requiring systemic corticosteroids.
The intensity of treatment depends on severity of symptoms: up to 3 treatments at 20-minute intervals as needed. In Steps 3 and 4, the preferred option includes the use of ICS-formoterol 1 to 2 pufs as needed up to a maximum total daily maintenance and rescue dose of 8 pufs (36 mcg). .
The purpose of this ERS clinical practice guideline is to provide recommendations for the use of as-needed ICS/formoterol in the absence of maintenance treatment in mild asthma based on a systematic review of the literature followed by the application of the GRADE approach.
Occupational asthma and work-aggravated asthma Every patient with adult-onset asthma should be asked about occupational exposures, and whether their asthma is better when they are away from work.
GINA now recommends that all adults and adolescents with asthma should receive either symptom-driven (in mild asthma) or daily low dose ICS-containing controller treatment, to reduce their risk of serious exacerbations.
1 Ιουλ 2021 · KEY POINTS. Adults with asthma should receive combination therapy with an inhaled corticosteroid and a long-acting beta-agonist on an as-needed basis for mild asthma or regular daily use for moderate or severe asthma. The recommended option is low-dose budesonide-formoterol, or beclomethasone-formoterol as an alternative.
